| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0895-4356(00)00260-2 |
| P698 | PubMed publication ID | 11165468 |
| P50 | author | Lewis Kuller | Q88077314 |
| P2093 | author name string | Ali S | |
| Shpilberg O | |||
| Evans RW | |||
| Kamboh MI | |||
| Shaten BJ | |||
| P2860 | cites work | Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma | Q24561687 |
| A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM | Q28191072 | ||
| The mysteries of lipoprotein(a) | Q28249594 | ||
| Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups | Q28276504 | ||
| cDNA sequence of human apolipoprotein(a) is homologous to plasminogen | Q28302632 | ||
| Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia | Q28307248 | ||
| Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group | Q28328155 | ||
| Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. | Q35171679 | ||
| Lipoprotein (a). Heterogeneity and biological relevance | Q37853403 | ||
| Structure and metabolism of lipoprotein (a) | Q40466905 | ||
| Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants | Q41148759 | ||
| Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study | Q41148799 | ||
| Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease | Q41346637 | ||
| Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. | Q43986314 | ||
| Hypervariable polymorphism of APO(a) in blacks and whites as reflected by phenotyping. | Q46258397 | ||
| No Association Between Plasma Lipoprotein(a) Concentrations and the Presence or Absence of Coronary Atherosclerosis in African-Americans | Q46405626 | ||
| A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants | Q47314597 | ||
| Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). | Q48754609 | ||
| Apolipoprotein (a): a comparison of isoforms identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis or by sodium dodecyl sulfate-agarose gel electrophoresis | Q48801311 | ||
| The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids | Q49122058 | ||
| Apolipoprotein(a) and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease. | Q51013111 | ||
| Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. | Q51031934 | ||
| Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population. | Q51061066 | ||
| Lipoprotein(a) and acute-phase proteins in acute myocardial infarction | Q51606314 | ||
| Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. | Q52626803 | ||
| Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study | Q57337243 | ||
| Apo(a) isoforms predict risk for coronary heart disease. A study in six populations | Q67549809 | ||
| Studies on apolipoprotein(a) phenotypes. Part 1. Phenotype frequencies in a healthy Japanese population | Q67569177 | ||
| Studies on apolipoprotein(a) phenotypes. Part 2. Phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with angiographically defined coronary artery diseases | Q67569190 | ||
| Lipoprotein(a) levels in black and white children and adolescents with IDDM | Q67900641 | ||
| Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy | Q68052637 | ||
| Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men | Q68125221 | ||
| Lipoprotein(a). A unique risk factor for atherothrombotic disease | Q68428387 | ||
| Transient changes of serum lipoprotein(a) as an acute phase protein | Q69102353 | ||
| Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction | Q69992538 | ||
| Lp(a) lipoprotein as a risk factor for myocardial infarction | Q70015411 | ||
| The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels | Q70021110 | ||
| Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies | Q70054174 | ||
| Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men | Q71125983 | ||
| Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial | Q71512983 | ||
| Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease | Q71769864 | ||
| Effect of sample storage on quantitation of lipoprotein(a) by an enzyme-linked immunosorbent assay | Q71814226 | ||
| Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail | Q71930751 | ||
| Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study | Q72030504 | ||
| Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age | Q72127538 | ||
| A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodies | Q72428845 | ||
| The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study | Q72551374 | ||
| Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease | Q72696273 | ||
| A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study | Q72711421 | ||
| Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension | Q74192227 | ||
| Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study | Q74314734 | ||
| Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians | Q74445989 | ||
| P433 | issue | 1 | |
| P921 | main subject | coronary artery disease | Q844935 |
| risk factor | Q1475848 | ||
| LPA | Q18028636 | ||
| P304 | page(s) | 51-57 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Journal of Clinical Epidemiology | Q6294959 |
| P1476 | title | Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial | |
| P478 | volume | 54 |
| Q42156986 | Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism |
| Q35737842 | Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality |
| Q35081894 | Lipoprotein(a): an emerging cardiovascular risk factor |
| Q35087598 | The role of non-LDL:non-HDL particles in atherosclerosis |
Search more.